Mcpherson'S Limited (MCP) AI Stock Analysis

• Market Cap: AU$26.63M
• Dividend Yield: N/A
• Average Volume (3M): 451.79K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.61
• Revenue Growth: -3.91%
• EPS Growth: 5.94%
• Country: AU
• Employees: 876
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): -0.02
• Shares Outstanding: 143,949,140
• 10 Day Avg. Volume: 1,155,699
• 30 Day Avg. Volume: 451,786
• PEG Ratio: -0.24
• Price to Book (P/B): 0.45
• Price to Sales (P/S): 0.23
• P/FCF Ratio: 20.71
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 46 Neutral
• Price Target: AU$0.18 ▼(-24.58% Downside)
• Action: Reiterated Date: 11/18/25
• Date: Action: Reiterated 11/18/25

The overall stock score is primarily impacted by financial performance challenges, including persistent profitability issues and cash flow concerns. Technical analysis indicates a bearish trend, and valuation metrics are weak due to a negative P/E ratio and lack of dividend yield. The absence of earnings call data and corporate events means these factors did not influence the score.

Positive Factors

Business model and distribution

McPherson's operates an integrated brand management and distribution model across retail and pharmacy channels, providing durable revenue streams from branded products and wholesale distribution. Long-term channel relationships and category management expertise support repeatable sales and merchandising leverage.

Top-line growth

Sustained double-digit revenue growth demonstrates expanding market penetration or successful product/marketing execution. A growing revenue base supports scale advantages, better negotiation with suppliers, and the ability to invest in marketing or new product development to sustain mid-term expansion.

Low leverage

Very low debt levels increase financial flexibility and reduce default risk, enabling the company to fund working capital, invest in growth initiatives, or absorb demand shocks without heavy refinancing. Improved leverage supports strategic optionality over the next several quarters.

Negative Factors

Persistent unprofitability

Despite revenue growth, the company has failed to convert sales into sustainable profits and delivers negative ROE. Prolonged unprofitability weakens the ability to self-fund expansion, undermines shareholder returns, and signals deeper issues in pricing, cost control or product mix that must be resolved for durable improvement.

Weak cash generation

A steep drop in free cash flow and poor cash conversion indicate liquidity stress and limited internal funding for capex or inventory. Over a multi-month horizon this raises refinancing and operational risk, constraining the company's ability to invest in brands or absorb margin pressure without external funding.

Operational margin pressure

An improving gross margin but negative operating profit suggests elevated SG&A, distribution or other operating costs. Persistent negative EBIT/EBITDA points to structural inefficiencies that limit ability to translate gross margin improvements into net profitability without cost restructuring or higher operational leverage.

Mcpherson'S Limited Business Overview & Revenue Model

Company Description

McPherson's Limited provides health, wellness, and beauty products in Australia, New Zealand, Asia, and internationally. It offers beauty care, hair care, skin care, and personal care items, including facial wipes, cotton pads, and foot comfort products; and vitamins and supplements, as well as various kitchen essentials, such as baking papers, cling wraps, and aluminium foils. The company sells its products primarily under the owned brands, including Dr. LeWinn's, A'kin, Manicare, Lady Jayne, Swisspers, Multix, Fusion Health, Oriental Botanicals, Moosehead, and Maseur. The company was founded in 1860 and is based in Kingsgrove, Australia.

How the Company Makes Money

McPherson's Limited generates revenue through multiple streams, primarily by selling a wide range of health and beauty products to retailers and wholesalers. The company operates on a wholesale distribution model, where it partners with various brands to provide their products to a broad customer base, including major retailers and e-commerce platforms. Key revenue streams include direct sales, private label offerings, and licensing agreements with both domestic and international brands. Additionally, McPherson's Limited benefits from strategic partnerships that enhance its market reach and product offerings, allowing for a steady flow of income through volume sales and brand collaborations.

Mcpherson'S Limited Financial Statement Overview

Summary

Mcpherson's Limited shows mixed financial health with strong revenue growth but persistent profitability issues. The balance sheet reflects improved leverage but negative returns on equity. Cash flow challenges persist, with declining free cash flow and low cash conversion ratios, indicating potential liquidity concerns.

Income Statement

Mcpherson's Limited has experienced fluctuating revenue growth, with a notable 24.14% increase in the latest period, but has consistently faced negative net profit margins, indicating ongoing profitability challenges. The gross profit margin improved significantly to 57.88%, but negative EBIT and EBITDA margins highlight operational inefficiencies.

Balance Sheet

The company's debt-to-equity ratio has improved to 0.10, reflecting better leverage management. However, the return on equity remains negative, indicating challenges in generating returns for shareholders. The equity ratio is stable, suggesting a balanced asset structure.

Cash Flow

Free cash flow has declined significantly by 68.55%, raising concerns about cash generation. The operating cash flow to net income ratio is low, indicating potential issues in converting income into cash. However, the free cash flow to net income ratio is relatively strong, suggesting some efficiency in cash utilization.

Breakdown	TTM	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021
Income Statement
Total Revenue	134.24M	138.99M	144.63M	155.23M	214.00M	200.50M
Gross Profit	62.31M	80.45M	35.09M	47.77M	90.80M	87.48M
EBITDA	-6.83M	-6.99M	-4.92M	3.10M	7.44M	5.98M
Net Income	-16.42M	-15.04M	-15.99M	-5.06M	333.00K	-5.37M
Balance Sheet
Total Assets	116.49M	117.21M	146.90M	190.06M	215.76M	199.59M
Cash, Cash Equivalents and Short-Term Investments	12.74M	9.48M	24.77M	7.03M	13.14M	7.35M
Total Debt	7.07M	7.30M	19.85M	25.45M	29.38M	20.93M
Total Liabilities	45.97M	44.23M	57.26M	80.61M	94.95M	84.96M
Stockholders Equity	70.52M	72.98M	89.64M	109.45M	120.81M	114.62M
Cash Flow
Free Cash Flow	6.08M	1.57M	9.64M	4.70M	16.32M	168.00K
Operating Cash Flow	6.31M	2.21M	12.34M	6.55M	18.57M	2.69M
Investing Cash Flow	-1.85M	-3.62M	16.29M	-1.85M	-2.25M	-31.80M
Financing Cash Flow	-3.54M	-13.91M	-10.90M	-10.91M	-10.59M	29.42M

Mcpherson'S Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.24
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:MCP, the sentiment is Negative. The current price of 0.24 is above the 20-day moving average (MA) of 0.19, above the 50-day MA of 0.22, and below the 200-day MA of 0.25, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 38.18 is Neutral, neither overbought nor oversold. The STOCH value of 20.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:MCP.

Mcpherson'S Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
S66	66 Neutral	AU$28.35M	5.26	14.70%	1.54%	6.89%	607.27%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
ABY	58 Neutral	AU$39.46M	123.53	1.90%	―	1.58%	-65.09%
MCP	46 Neutral	AU$26.63M	-1.62	-20.06%	―	-3.91%	5.94%
PTL	46 Neutral	AU$6.82M	-6.35	-22.96%	―	-25.16%	77.62%
CCX	46 Neutral	AU$42.37M	-7.64	-24.80%	―	2.35%	95.03%
SKN	45 Neutral	AU$18.00M	―	―	―	12.92%	34.21%

Mcpherson'S Limited Corporate Events

McPherson’s Unveils $2 Million On-Market Share Buy-Back as Part of Capital Management Drive

McPherson’s Limited, a Sydney-based ASX-listed supplier of health and beauty products under brands such as Manicare, Swisspers and Dr. LeWinn’s, targets consumers through pharmacy, grocery, health food and online retail channels. The company continues to position its core brands at the centre of its growth strategy, leveraging multiple distribution channels to deepen market reach.

The company has announced an on-market share buy-back of up to $2 million to be conducted over the next 12 months starting in March 2026. The board frames the buy-back as part of a broader capital allocation framework aimed at returning capital to shareholders, optimising capital management and enhancing shareholder value, while preserving flexibility for future growth and operating within regulatory limits that avoid the need for shareholder approval.

The most recent analyst rating on (AU:MCP) stock is a Hold with a A$0.19 price target. To see the full list of analyst forecasts on Mcpherson’S Limited stock, see the AU:MCP Stock Forecast page.

McPherson’s Sets Webcast to Present 1H26 Financial Results

McPherson’s Limited, a Sydney-based ASX-listed supplier of health and beauty products built around brands such as Manicare, Swisspers, Lady Jayne, Dr. LeWinn’s and Fusion Health, targets consumers via pharmacy, grocery, health food and online channels. The company has announced that its financial results for the half year ended 31 December 2025 will be presented in a webcast and conference call on 25 February 2026, giving shareholders an opportunity to hear directly from senior management and pose questions, which may provide fresh insight into trading performance and strategic direction for stakeholders.

The briefing will be hosted by Chief Executive Officer and Managing Director Brett Charlton alongside Chief Financial Officer Mark Sherwin, underscoring the importance of the half-year update to the market. By engaging investors through both teleconference and webcast, McPherson’s is aiming to maintain transparency and strengthen investor relations at a time when performance in the health and beauty sector and the trajectory of its core brands remain key to its market positioning.

The most recent analyst rating on (AU:MCP) stock is a Hold with a A$0.19 price target. To see the full list of analyst forecasts on Mcpherson’S Limited stock, see the AU:MCP Stock Forecast page.

McPherson’s trims costs, lifts cash as new operating model beds down despite 1H loss

McPherson’s reported revenue from continuing operations of $66.0 million for the half year to 31 December 2025, a 6.7% decline, but maintained largely stable core brand sales at $61.9 million as Manicare and Swisspers delivered solid growth while Dr LeWinn’s and Fusion Health lagged. The shift to a new operating model reduced fixed costs, lifting underlying EBITDA 10.6% to $2.2 million and supporting a net cash position of $12.6 million, despite a statutory net loss of $2.3 million driven by a non-cash impairment and one-off items.

Management highlighted that the transition to pharmacy wholesalers, SKU rationalisation, and logistics outsourcing caused temporary revenue and supply disruptions, particularly for Dr LeWinn’s and Fusion Health, but said corrective actions and restored stock levels should support gradual improvement in the second half. The board opted against paying a dividend but authorised an on-market share buyback of up to A$2.0 million, signalling confidence in the company’s strategy and the scalability of its new operating model for future growth and shareholder returns.

The most recent analyst rating on (AU:MCP) stock is a Hold with a A$0.19 price target. To see the full list of analyst forecasts on Mcpherson’S Limited stock, see the AU:MCP Stock Forecast page.

McPherson’s Announces Departure of Director Jane McKellar and Discloses Final Shareholding

McPherson’s Limited has announced the cessation of director Jane Matisse McKellar from the company’s board effective 31 January 2026, in accordance with ASX listing rule disclosure requirements. At the time of her departure, McKellar held a total of 11,533 ordinary shares in McPherson’s Limited, with no additional indirect holdings or interests in related contracts disclosed, providing investors with clarity on her remaining equity stake and potential ongoing alignment with the company’s performance.

The most recent analyst rating on (AU:MCP) stock is a Hold with a A$0.23 price target. To see the full list of analyst forecasts on Mcpherson’S Limited stock, see the AU:MCP Stock Forecast page.

McPherson’s Limited Announces Board Restructuring

McPherson’s Limited has announced that Mr. Ari Mervis will resume his role as Board Chairman from 1 February 2026, with Ms. Alison Cook continuing as a non-executive director and taking on the role of Chairman of the newly renamed Remuneration, People & Culture Committee. The company will also combine its Audit and Risk & Compliance Committees into a single Audit & Risk Committee, chaired by Ms. Helen Thornton, and establish a separate Nominations Committee led by Mr. Mervis. These changes are part of McPherson’s ongoing efforts to streamline its governance structure and enhance operational efficiency.

The most recent analyst rating on (AU:MCP) stock is a Hold with a A$0.22 price target. To see the full list of analyst forecasts on Mcpherson’S Limited stock, see the AU:MCP Stock Forecast page.